B. Bahar

B. Bahar, F. Saddadi, A. Alidadi, 2017, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

Original article Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation

A. Shamshiri, K. Alimoghaddam, A. Ghavamzadeh, 2008 .

Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation.

A. Shamshiri, K. Alimoghaddam, A. Ghavamzadeh, 2008, Urologic oncology.

The effectiveness of non-myeloablative stem cell transplantation and DLI as a selective treatment in class III ß-thalassemic patients

A. Ghavamzadeh, B. Bahar, M. Iravani, 2011 .

Peripheral Blood Stem Cell Transplantation in Patients with Beta-Thalassemia Major

A. Ghavamzadeh, B. Bahar, M. Iravani, 2004 .

Comparison of 60 and 80 mg/m2 of daunorubicin in induction therapy of acute myeloid leukaemia

A. Kasaeian, K. Alimoghaddam, A. Ghavamzadeh, 2017, Hematological oncology.

Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy.

N. Aghdami, K. Alimoghaddam, A. Ghavamzadeh, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Mutation Analysis of KRAS and BRAF Genes in Metastatic Colorectal Cancer: a First Large Scale Study from Iran.

M. Sohrabi, F. Zamani, H. Rezvani, 2016, Asian Pacific journal of cancer prevention : APJCP.

Imipenem/Cilastatin versus Cefepime as Empiric Monotherapy for Fever in Neutropenic Patients after ematopoietic Stem Cell Transplantation

K. Alimoghaddam, A. Ghavamzadeh, B. Bahar, 2005 .

ALLOGENEIC PERIPHERAL BLOOD AND BONE MARROW STEM CELL TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA: A SINGLE CENTER STUDY

A. Ghavamzadeh, B. Bahar, M. Iravani, 2003 .

Long--Term Free Survival of Two Class III β-Thalassemic Patients after Non-Myeloablative Stem Cell Transplantation

K. Alimoghaddam, A. Ghavamzadeh, S. Mousavi, 2020, International journal of hematology-oncology and stem cell research.

Non-Myeloablative Stem Cell Transplantation in Hematologic Malig¬nancies: An Experience from the Hematology-Oncology and BMT Re¬search Center

A. Shamshiri, K. Alimoghaddam, A. Ghavamzadeh, 2004 .

PREDICTIVE SIGNIFICANCE OF SERUM INTERLEUKIN-10 FOR ACUTE GRAFT VERSUS HOST DISEASE PRIOR TO ALLOGENEIC BONE MARROW TRASPLANTATION

A. Ardalan, B. Bahar, Ghavamzadeh Ardeshir, 2005 .

Original paper Study of relationship between IL-1Ra gene polymorphism and GVHD in HLA – identical sibling allogenic transplants

A. Ghavamzadeh, A. Fotouhi, M. Noori-Daloii, 2007 .

Hematopoietic Stem Cell Transplantation in Patients with Severe Acquired Aplastic Anemia: Iranian Experience

K. Alimoghaddam, A. Ghavamzadeh, A. Hamidieh, 2011 .

Long-term results of non-fludarabine versus fludarabine-based stem cell transplantation without total body irradiation in Fanconi anemia patients.

K. Alimoghaddam, A. Ghavamzadeh, A. Hamidieh, 2011, Hematology/oncology and stem cell therapy.

Frequency, risk factors, and outcome of acute kidney injury following bone marrow transplantation at Dr Shariati Hospital in Tehran.

K. Falaknazi, B. Bahar, I. Najafi, 2010, Iranian journal of kidney diseases.

Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: a retrospective single‐center study

A. Kasaeian, K. Alimoghaddam, A. Ghavamzadeh, 2017, Hematological oncology.

A. Ghavamzadeh, K. Alimoghadam, B. Bahar, 2004 .

Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia.

K. Alimoghaddam, A. Ghavamzadeh, M. Jalili, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Outcome of Allogeneic Hematopoietic Stem Cell Transplants Without Total Body Irradiation in Pediatric Patients With Acute Lymphoblastic Leukemia: Single Centre Experience

K. Alimoghaddam, A. Ghavamzadeh, A. Hamidieh, 2012, Journal of pediatric hematology/oncology.

Stem Cell Transplantation in Iran; 1991 until 2009

F. Khatami, B. Bahar, A. Jalali, 2009 .

Stem cell transplantation; Iranian experience.

M. Iravani, K. Alimoghaddam, A. Ghavamzadeh, 2009, Archives of Iranian medicine.

Hematopoietic stem cell transplantation in Iran: 1991 to 2008.

A. Ghavamzadeh, F. Khatami, M. Jahani, 2008, Hematology/oncology and stem cell therapy.

Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran.

Hamid Reza Ghaffari, K. Alimoghaddam, A. Ghavamzadeh, 2005, Archives of Iranian medicine.

Peripheral blood versus bone marrow transplant in patients with aplastic anemia, an unresolved issue

A. Kasaeian, K. Alimoghaddam, A. Ghavamzadeh, 2016, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation in acute promyelocytic leukemia, experience in Iran.

K. Alimoghaddam, A. Ghavamzadeh, S. Rostami, 2011, Archives of Iranian medicine.

BCR-ABL FUSION TRANSCRIPT DETECTION IN IRANIAN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

M. Irvani, B. Bahar, Ghavamzadeh Ardeshir, 2008 .

Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation

A. Ghavamzadeh, B. Bahar, A. Ashouri, 2005, Bone Marrow Transplantation.

YEARS EXPERIENCE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN IRAN

F. Khatami, M. Jalili, B. Bahar, 2008 .

JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia.

W. Ageno, H. Dargahi, K. Alimoghaddam, 2009, Leukemia research.

Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Fanconi Anemia

A. Kasaeian, K. Alimoghaddam, A. Ghavamzadeh, 2016, Mediterranean journal of hematology and infectious diseases.

Effect on growth parameters of bone marrow transplantation with a chemotherapy-only conditioning regimen.

B. Larijani, M. Khoshniat, A. Ghavamzadeh, 2003, Transplantation proceedings.

graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation

A. Ghavamzadeh, B. Bahar, A. Ashouri, 2005 .

FIRST COMPLETE REMISSION VERSUS OTHER- THAN- FIRST COMPLETE REMISSION IN ACUTE MYELOGENOUS LEUKEMIA WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

F. Khatami, B. Bahar, A. Jalali, 2009 .

Thyroid, parathyroid, gonadal, and pancreatic beta-cell function after bone marrow transplantation with chemotherapy-only conditioning.

B. Larijani, M. Khoshniat, A. Ghavamzadeh, 2003, Transplantation proceedings.

The Outcomes of Esophageal and Gastric Cancer Treatments in a Retrospective Study, Single Center Experience

K. Alimoghaddam, A. Ghavamzadeh, F. Ghaffari, 2014, International journal of hematology-oncology and stem cell research.

Treatment of new cases of Acute Promyelocytic Leukemia With Arsenic Trioxide

N. Aghdami, K. Alimoghaddam, A. Ghavamzadeh, 2005 .

RESULTS OF HEMATOPOIETIC CELL TRANSPLANTATION IN PEDIATRIC LEUKEMIA

B. Bahar, A. Ashouri, M. Iravani, 2008 .

Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.

M. Yaghmaie, A. Ghavamzadeh, S. Mousavi, 2008, Archives of Iranian medicine.

Effects of different suture materials on wound healing and infection in subcutaneous closure techniques.

B. Sancak, B. Bahar, Z. Türkyılmaz, 2009, B-ENT.

THALASSEMIA: INCIDENCE AND PREDICTIVE FACTORS FOR CHRONIC GVHD AFTER HLA-IDENTICAL SIBLING MARROW TRANSPLANTATION

B. Bahar, M. Jahani, G. Ardeshir, 2002 .

Evaluation of JAK2V617F mutation prevalence in Myeloproliferative Neoplasm by AS-RT-PCR

H. Dargahi, A. Ghavamzadeh, F. Nadali, 2009 .